Tumor PIK3CA genotype and prognosis: A pooled analysis of 4,241 patients (pts) with early-stage breast cancer (BC)

D. Zardavas, L. Te Marvelde, R. Milne, H. Joensuu, M. E. Moynahan, B. Hennessy, I. Bieche, L. H. Saal, O. Stal, B. Iacopetta, J. D. Jensen, S. O'Toole, M. Barbareschi, S. Noguchi, E. Lerma, Q. Wang, M. J. Piccart-Gebhart, C. Sotiriou, S. Michiels, S. Loi

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
Artikelnummer516
TidsskriftJournal of Clinical Oncology
Vol/bind33
Udgave nummer15 Supplement
ISSN0732-183X
StatusUdgivet - 2015
BegivenhedAnnual Meeting of the American-Society-of-Clinical-Oncology - Chicago, USA
Varighed: 29. maj 20152. jun. 2015

Konference

KonferenceAnnual Meeting of the American-Society-of-Clinical-Oncology
LandUSA
ByChicago
Periode29/05/201502/06/2015

Bibliografisk note

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) MAY 29-JUN 02, 2015 Chicago, IL Amer Soc Clin Oncol 0 S

Citationsformater

Zardavas, D., Te Marvelde, L., Milne, R., Joensuu, H., Moynahan, M. E., Hennessy, B., Bieche, I., Saal, L. H., Stal, O., Iacopetta, B., Jensen, J. D., O'Toole, S., Barbareschi, M., Noguchi, S., Lerma, E., Wang, Q., Piccart-Gebhart, M. J., Sotiriou, C., Michiels, S., & Loi, S. (2015). Tumor PIK3CA genotype and prognosis: A pooled analysis of 4,241 patients (pts) with early-stage breast cancer (BC). Journal of Clinical Oncology, 33(15 Supplement), [516].